H.V Curran - Publications

Affiliations: 
UCL  

36/271 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Elliott M, Terrett G, Curran HV, De Bono N, Rendell PG, Henry JD. Deficits in episodic future thinking following acute alcohol consumption. Psychopharmacology. 239: 2445-2455. PMID 35419636 DOI: 10.1007/s00213-022-06136-2  0.333
2021 Elliott M, Terrett G, Curran HV, De Bono N, Rendell PG, Henry JD. Prospective memory deficits following acute alcohol consumption. Journal of Psychopharmacology (Oxford, England). 35: 1386-1397. PMID 34747256 DOI: 10.1177/02698811211056195  0.337
2019 Das RK, Gale G, Walsh K, Hennessy VE, Iskandar G, Mordecai LA, Brandner B, Kindt M, Curran HV, Kamboj SK. Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nature Communications. 10: 5187. PMID 31772157 DOI: 10.1016/J.Biopsych.2020.02.498  0.333
2019 Lawn W, Mithchener L, Freeman TP, Benattayallah A, Bisby JA, Wall MB, Dodds CM, Curran HV, Morgan CJA. Value-based decision-making of cigarette and nondrug rewards in dependent and occasional cigarette smokers: An FMRI study. Addiction Biology. e12802. PMID 31328850 DOI: 10.1111/Adb.12802  0.613
2019 Yim J, Hindocha C, Yamamori Y, Jones A, Walker H, Lawn W, Lewis G, Howes O, Curran H, Freeman T, Bloomfield M. P.4.03 The acute effects of cannabidiol on reward processing in humans: an fMRI study European Neuropsychopharmacology. 29: S702-S703. DOI: 10.1016/J.Euroneuro.2019.01.093  0.302
2018 Hindocha C, Freeman TP, Grabski M, Crudgington H, Davies AC, Stroud JB, Das RK, Lawn W, Morgan CJA, Curran HV. The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers. Scientific Reports. 8: 7568. PMID 29765102 DOI: 10.1038/S41598-018-25846-2  0.401
2017 Freeman TP, Pope RA, Wall MB, Bisby JA, Luijten M, Hindocha C, Mokrysz C, Lawn W, Moss A, Bloomfield MAP, Morgan CJA, Nutt DJ, Curran HV. Cannabis dampens the effects of music in brain regions sensitive to reward and emotion. The International Journal of Neuropsychopharmacology. PMID 29025134 DOI: 10.1093/Ijnp/Pyx082  0.643
2017 Freeman T, Pope R, Wall M, Bisby J, Luijten M, Hindocha C, Mokrysz C, Lawn W, Moss A, Bloomfield M, Morgan C, Nutt D, Curran H. Cannabis increases wanting but not liking of music and dampens its rewarding effects on the brain European Neuropsychopharmacology. 27: S92-S93. DOI: 10.1016/S0924-977X(17)30164-5  0.636
2016 Freeman TP, Pope RA, Wall MB, Bisby JA, Luijten M, Hindocha C, Lawn W, Mokrysz C, Moss A, Bloomfield MAP, Morgan CJA, Nutt DJ, Curran HV. Dissociable effects of cannabinoids on anticipatory and consummatory reward processing The International Journal of Neuropsychopharmacology. 19: 6-7. DOI: 10.1093/Ijnp/Pyw041.298  0.638
2016 Curran HV, Wall M, Demetriou L, Carhart-Harris R, Fergusson B, Nutt D. Effects of ecstasy on autobiographical memories: implications for MDMA assisted psychotherapy European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)30948-8  0.381
2015 Lawn W, Freeman T, Pope R, Joyce A, Harvey L, Hindocha C, Mokrysz C, Moss A, Das R, Curran H. P.6.d.006 I was gonna process rewards – but then I got high: the acute and chronic effects of cannabis and ketamine on reward processing European Neuropsychopharmacology. 25: S614-S615. DOI: 10.1016/S0924-977X(15)30868-3  0.306
2015 Curran HV, Carhart-Harris R, Nutt D, Ferguson B. S.25.02 Effects of MDMA on self-referent encoding and personal memories: implications for its use in PTSD European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30112-7  0.336
2014 Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, Tanner M, Bloomfield M, Williams TM, Bolstridge M, Stewart L, Morgan CJ, Newbould RD, Feilding A, Curran HV, et al. The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 527-40. PMID 24345398 DOI: 10.1017/S1461145713001405  0.403
2013 Kamboj SK, Joye A, Bisby JA, Das RK, Platt B, Curran HV. Processing of facial affect in social drinkers: a dose-response study of alcohol using dynamic emotion expressions. Psychopharmacology. 227: 31-9. PMID 23263458 DOI: 10.1007/S00213-012-2940-5  0.653
2012 Griffiths A, Hill R, Morgan C, Rendell PG, Karimi K, Wanagaratne S, Curran HV. Prospective memory and future event simulation in individuals with alcohol dependence. Addiction (Abingdon, England). 107: 1809-16. PMID 22578026 DOI: 10.1111/j.1360-0443.2012.03941.x  0.308
2012 Morgan CJ, Gardener C, Schafer G, Swan S, Demarchi C, Freeman TP, Warrington P, Rupasinghe I, Ramoutar A, Tan N, Wingham G, Lewis S, Curran HV. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychological Medicine. 42: 391-400. PMID 21798112 DOI: 10.1017/S0033291711001322  0.339
2012 Freeman TP, Morgan CJ, Beesley T, Curran HV. Drug cue induced overshadowing: selective disruption of natural reward processing by cigarette cues amongst abstinent but not satiated smokers. Psychological Medicine. 42: 161-71. PMID 21733292 DOI: 10.1017/S0033291711001139  0.305
2011 Freeman T, Morgan C, Beesley T, Curran H. P.6.c.003 Drug cue induced overshadowing: disruption of natural reward processing by cigarette cues amongst abstinent but not satiated smokers European Neuropsychopharmacology. 21: S577. DOI: 10.1016/S0924-977X(11)70943-9  0.303
2010 Mackenzie Ross SJ, Brewin CR, Curran HV, Furlong CE, Abraham-Smith KM, Harrison V. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicology and Teratology. 32: 452-9. PMID 20227490 DOI: 10.1016/J.Ntt.2010.03.004  0.446
2010 Bisby JA, King JA, Brewin CR, Burgess N, Curran HV. Acute effects of alcohol on intrusive memory development and viewpoint dependence in spatial memory support a dual representation model. Biological Psychiatry. 68: 280-6. PMID 20202625 DOI: 10.1016/J.Biopsych.2010.01.010  0.724
2010 Brown J, Brignell CM, Dhiman SK, Curran HV, Kamboj SK. Acute effects of alcohol on memory: impact of emotional context and serial position. Neurobiology of Learning and Memory. 93: 428-34. PMID 20045075 DOI: 10.1016/j.nlm.2009.12.010  0.344
2010 Paraskevaides T, Morgan CJ, Leitz JR, Bisby JA, Rendell PG, Curran HV. Drinking and future thinking: acute effects of alcohol on prospective memory and future simulation. Psychopharmacology. 208: 301-8. PMID 19967530 DOI: 10.1007/S00213-009-1731-0  0.668
2010 Bisby JA, Leitz JR, Morgan CJ, Curran HV. Decreases in recollective experience following acute alcohol: a dose-response study. Psychopharmacology. 208: 67-74. PMID 19911170 DOI: 10.1007/S00213-009-1709-Y  0.675
2009 Leitz JR, Morgan CJ, Bisby JA, Rendell PG, Curran HV. Global impairment of prospective memory following acute alcohol. Psychopharmacology. 205: 379-87. PMID 19440700 DOI: 10.1007/S00213-009-1546-Z  0.675
2009 Clair J, Martin L, Bond AJ, O'Ryan D, Davis P, Curran HV. An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men. Journal of Psychopharmacology (Oxford, England). 23: 428-35. PMID 18562417 DOI: 10.1177/0269881108091880  0.319
2006 Kamboj SK, Curran HV. Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust. Psychopharmacology. 185: 529-35. PMID 16555061 DOI: 10.1007/S00213-006-0332-4  0.334
2001 Curran HV, Kleckham J, Bearn J, Strang J, Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study. Psychopharmacology. 154: 153-60. PMID 11314677 DOI: 10.1007/S002130000628  0.3
2000 Milani R, Curran HV. Effects of a low dose of alcohol on recollective experience of illusory memory. Psychopharmacology. 147: 397-402. PMID 10672633 DOI: 10.1007/S002130050008  0.417
1999 Curran HV, Hildebrandt M. Dissociative effects of alcohol on recollective experience. Consciousness and Cognition. 8: 497-509. PMID 10600247 DOI: 10.1006/Ccog.1999.0417  0.431
1999 Bishop KI, Curran HV. An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming. Psychopharmacology. 140: 345-53. PMID 9877014 DOI: 10.1007/S002130050775  0.401
1998 Gorissen ME, Curran HV, Eling PA. Proactive interference and temporal context encoding after diazepam intake. Psychopharmacology. 138: 334-43. PMID 9725756 DOI: 10.1007/S002130050679  0.365
1998 Curran HV, Pooviboonsuk P, Dalton JA, Lader MH. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology. 135: 27-36. PMID 9489931 DOI: 10.1007/S002130050482  0.401
1996 Bishop KI, Curran HV. Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil. Psychopharmacology. 121: 267-78. PMID 8545533 DOI: 10.1007/Bf02245638  0.396
1995 Curran HV, Barrow S, Weingartner H, Lader M, Bernik M. Encoding, remembering and awareness in lorazepam-induced amnesia. Psychopharmacology. 122: 187-93. PMID 8848535 DOI: 10.1007/Bf02246094  0.337
1995 Curran HV, Bond A, O'Sullivan G, Bruce M, Marks I, Lelliot P, Shine P, Lader M. Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder. Psychological Medicine. 24: 969-76. PMID 7892364 DOI: 10.1017/S0033291700029056  0.368
1988 Eves FF, Curran HV, Shine P, Lader MH. The effects on memory of pipequaline, alone or in combination with diazepam. Psychopharmacology. 95: 386-9. PMID 3137626 DOI: 10.1007/Bf00181953  0.376
Low-probability matches (unlikely to be authored by this person)
2009 Mason O, Morgan CJ, Dhiman SK, Patel A, Parti N, Patel A, Curran HV. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis. Psychological Medicine. 39: 951-6. PMID 19017430 DOI: 10.1017/S0033291708004741  0.296
2023 Elliott M, Terrett G, Curran HV, Rendell PG, Henry JD. Episodic foresight is impaired following acute alcohol intoxication. Journal of Psychopharmacology (Oxford, England). 2698811231154851. PMID 36825668 DOI: 10.1177/02698811231154851  0.295
2007 Brignell CM, Rosenthal J, Curran HV. Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. Journal of Psychopharmacology (Oxford, England). 21: 673-83. PMID 17606475 DOI: 10.1177/0269881107077351  0.295
2008 Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ, Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug and Alcohol Dependence. 95: 219-29. PMID 18355990 DOI: 10.1016/J.Drugalcdep.2008.01.024  0.291
2012 Allen D, Curran HV, Lader M. Effects of lofepramine and dothiepin on memory and psychomotor function in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 7: 33-8. PMID 22290368 DOI: 10.1177/0269881193007001061  0.291
1991 Curran HV, Schifano F, Lader M. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology. 103: 83-90. PMID 2006245 DOI: 10.1007/BF02244079  0.291
1987 Curran HV. Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biological Psychology. 23: 179-213. PMID 2878691 DOI: 10.1016/0301-0511(86)90081-5  0.29
1996 Pompéia S, Gorenstein C, Curran HV. Benzodiazepine effects on memory tests: dependence on retrieval cues? International Clinical Psychopharmacology. 11: 229-36. PMID 9031988  0.287
2015 Lawn W, Freeman TP, Hindocha C, Mokrysz C, Das RK, Morgan CJ, Curran HV. The effects of nicotine dependence and acute abstinence on the processing of drug and non-drug rewards. Psychopharmacology. 232: 2503-17. PMID 25757672 DOI: 10.1007/S00213-015-3883-4  0.287
2006 Kamboj SK, Curran HV. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine. Psychopharmacology. 188: 482-8. PMID 17047934 DOI: 10.1007/s00213-006-0552-7  0.286
2015 Platt B, Kamboj SK, Italiano T, Rendell PG, Curran HV. Prospective memory impairments in heavy social drinkers are partially overcome by future event simulation. Psychopharmacology. PMID 26612619 DOI: 10.1007/s00213-015-4145-1  0.281
2015 Charles M, Wellington CE, Mokrysz C, Freeman TP, O'Ryan D, Curran HV. Attentional bias and treatment adherence in substitute-prescribed opiate users. Addictive Behaviors. 46: 100-5. PMID 25838001 DOI: 10.1016/J.Addbeh.2015.03.017  0.281
2018 Morgan CJA, Freeman TP, Hindocha C, Schafer G, Gardner C, Curran HV. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Translational Psychiatry. 8: 181. PMID 30185793 DOI: 10.1038/s41398-018-0191-x  0.281
2008 Morgan CJA, Rees H, Curran HV. Attentional bias to incentive stimuli in frequent ketamine users. Psychological Medicine. 38: 1331-1340. PMID 18177527 DOI: 10.1017/S0033291707002450  0.28
2016 Bloomfield MA, Mouchlianitis E, Morgan CJ, Freeman TP, Curran HV, Roiser JP, Howes OD. Salience attribution and its relationship to cannabis-induced psychotic symptoms. Psychological Medicine. 1-13. PMID 27628967 DOI: 10.1017/S0033291716002051  0.28
2012 Robbins T, Curran H, de Wit H. Special issue on impulsivity and compulsivity. Psychopharmacology. 219: 251-2. PMID 22124671 DOI: 10.1007/S00213-011-2584-X  0.279
1989 Curran HV, Sakulsriprong M, Lader M. Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology. 95: 520-7. PMID 3212150 DOI: 10.1007/BF00172967  0.278
2014 Stewart LH, Ferguson B, Morgan CJ, Swaboda N, Jones L, Fenton R, Wall MB, Curran HV. Effects of ecstasy on cooperative behaviour and perception of trustworthiness: a naturalistic study. Journal of Psychopharmacology (Oxford, England). 28: 1001-8. PMID 25122044 DOI: 10.1177/0269881114544775  0.277
2002 Curran HV, Brignell C, Fletcher S, Middleton P, Henry J. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology. 164: 61-70. PMID 12373420 DOI: 10.1007/s00213-002-1169-0  0.277
2019 Yamamori Y, Hindocha C, Yim J, Jones A, Walker H, Lewis G, Howes O, Curran H, Roiser J, Freeman T, Bloomfield M. P.3.03 The acute effects of cannabidiol on emotional processing and anxiety: A neurocognitive imaging study European Neuropsychopharmacology. 29: S680. DOI: 10.1016/J.Euroneuro.2019.01.065  0.276
2010 Morgan CJ, Schafer G, Freeman TP, Curran HV. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. The British Journal of Psychiatry : the Journal of Mental Science. 197: 285-90. PMID 20884951 DOI: 10.1192/bjp.bp.110.077503  0.275
2012 Curran HV. Memory functions, alertness and mood of long-term benzodiazepine users: a preliminary investigation of the effects of a normal daily dose. Journal of Psychopharmacology (Oxford, England). 6: 69-75. PMID 22291244 DOI: 10.1177/026988119200600113  0.273
2015 Mercuri K, Terrett G, Henry JD, Bailey PE, Curran HV, Rendell PG. Episodic foresight deficits in long-term opiate users. Psychopharmacology. 232: 1337-45. PMID 25323626 DOI: 10.1007/s00213-014-3772-2  0.272
1992 Curran HV. Benzodiazepines, memory and mood: a review. Psychopharmacology. 105: 1-8. PMID 1684055 DOI: 10.1007/BF02316856  0.272
2016 Mokrysz C, Landy R, Gage SH, Munafò MR, Roiser JP, Curran HV. Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study. Journal of Psychopharmacology (Oxford, England). 30: 159-68. PMID 26739345 DOI: 10.1177/0269881115622241  0.272
2019 Green S, Hindocha C, Yamamori Y, Yim JLL, Jones APM, Walker HR, Lewis G, Howes OD, Curran HV, Freeman TP, Bloomfield MAP. P.3.19 The effects of cannabidiol on cerebral blood flow and its relationship to memory: an arterial spin labelling study European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.01.081  0.27
2018 Mercuri K, Terrett G, Henry JD, Curran HV, Elliott M, Rendell PG. Episodic foresight deficits in regular, but not recreational, cannabis users. Journal of Psychopharmacology (Oxford, England). 269881118776672. PMID 29897004 DOI: 10.1177/0269881118776672  0.269
1996 Pooviboonsuk P, Dalton JA, Curran HV, Lader MH. The effects of single doses of lorazepam on event-related potentials and cognitive function Human Psychopharmacology: Clinical and Experimental. 11: 241-252. DOI: 10.1002/(Sici)1099-1077(199605)11:3<241::Aid-Hup795>3.0.Co;2-0  0.266
2013 Curran HV, Robbins TW. Special issue on consolidation, reconsolidation and extinction. Psychopharmacology. 226: 627-9. PMID 23494239 DOI: 10.1007/s00213-013-3058-0  0.263
2002 Pompéia S, Rusted JM, Curran HV. Verbal fluency facilitated by the cholinergic blocker, scopolamine. Human Psychopharmacology. 17: 51-9. PMID 12404707 DOI: 10.1002/Hup.331  0.263
1999 Curran HV. Effects of anxiolytics on memory Human Psychopharmacology: Clinical and Experimental. 14: S72-S79. DOI: 10.1002/(sici)1099-1077(199908)14:1+3.0.co;2-0  0.262
2009 Freeman T, Morgan C, Schafer G, Curran H. P.2.a.028 Acute and chronic effects of naturalistically smoked cannabis on depression and anxiety European Neuropsychopharmacology. 19: S376. DOI: 10.1016/S0924-977X(09)70577-2  0.262
2020 Das RK, Gale G, Walsh K, Hennessy VE, Iskandar G, Mordecai LA, Brandner B, Kindt M, Curran HV, Kamboj SK. Author Correction: Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nature Communications. 11: 3065. PMID 32528103 DOI: 10.1038/S41467-020-16762-Z  0.262
2014 Hindocha C, Freeman T, Schafer G, Gardener C, Morgan C, Curran H. P.3.d.009 Individual and combined effects of delta-9-tetrahydrocannabinol and cannabidiol on model psychosis and memory function European Neuropsychopharmacology. 24: S526. DOI: 10.1016/S0924-977X(14)70842-9  0.261
2014 Freeman TP, Stone JM, Orgaz B, Noronha LA, Minchin SL, Curran HV. Tobacco smoking in schizophrenia: investigating the role of incentive salience. Psychological Medicine. 44: 2189-97. PMID 24176189 DOI: 10.1017/S0033291713002705  0.261
2014 Kamboj SK, Conroy L, Tookman A, Carroll E, Jones L, Curran HV. Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids. European Journal of Pain (London, England). 18: 1376-84. PMID 24700581 DOI: 10.1002/J.1532-2149.2014.498.X  0.26
2009 Whiteley C, Wanigaratne S, Marshall J, Curran HV. Autobiographical memory in detoxified dependent drinkers. Alcohol and Alcoholism (Oxford, Oxfordshire). 44: 429-30. PMID 19293147 DOI: 10.1093/alcalc/agp013  0.258
2017 Mokrysz C, Shaban N, Freeman TP, Curran HV. Acute effects of cannabis on the experience of speech illusion: a placebo-controlled study in adolescents and adults European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)30145-1  0.257
1999 Kiliç C, Curran HV, Noshirvani H, Marks IM, Başoğlu M. Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients. Psychological Medicine. 29: 225-31. PMID 10077311 DOI: 10.1017/s003329179800734x  0.255
2010 Morgan CJ, Rothwell E, Atkinson H, Mason O, Curran HV. Hyper-priming in cannabis users: a naturalistic study of the effects of cannabis on semantic memory function. Psychiatry Research. 176: 213-8. PMID 20122742 DOI: 10.1016/j.psychres.2008.09.002  0.253
2003 Curran HV, Collins R, Fletcher S, Kee SCY, Woods B, Iliffe S. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life Psychological Medicine. 33: 1223-1237. PMID 14580077 DOI: 10.1017/S0033291703008213  0.252
1991 Sakulsripong M, Curran HV, Lader M. Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo. European Journal of Clinical Pharmacology. 40: 43-8. PMID 2060544 DOI: 10.1007/BF00315137  0.252
2012 Curran HV, Gorenstein C, Lader M. Comparative amnesic and sedative effects of lorazepam and oxazepam in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 7: 249-56. PMID 22290838 DOI: 10.1177/026988119300700303  0.252
2008 Friswell J, Phillips C, Holding J, Morgan CJ, Brandner B, Curran HV. Acute effects of opioids on memory functions of healthy men and women. Psychopharmacology. 198: 243-50. PMID 18379759 DOI: 10.1007/s00213-008-1123-x  0.251
1996 Curran HV. State-Dependency In Humans: Drug And Mood Effects Revisited Behavioural Pharmacology. 7: 22. DOI: 10.1097/00008877-199605001-00049  0.251
2017 Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology. PMID 29085980 DOI: 10.1007/S00213-017-4754-Y  0.251
1986 Curran HV, Shine P, Lader M. Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation. Psychopharmacology. 89: 360-3. PMID 3088664 DOI: 10.1007/BF00174375  0.25
2009 Morgan C, Mason O, Duffen S, Hunt S, Monaghan L, Curran H. P.6.c.013 Prodromal symptoms and neurocognitive profile of 3 groups of dependent drug users: cannabis, ketamine and cocaine European Neuropsychopharmacology. 19: S657. DOI: 10.1016/S0924-977X(09)71059-4  0.25
2018 Braidwood R, Mansell S, Waldron J, Rendell PG, Kamboj SK, Curran HV. Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability. Frontiers in Psychiatry. 9: 97. PMID 29636705 DOI: 10.3389/fpsyt.2018.00097  0.249
2004 Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 208-18. PMID 14603267 DOI: 10.1038/sj.npp.1300342  0.248
2014 Terrett G, McLennan SN, Henry JD, Biernacki K, Mercuri K, Curran HV, Rendell PG. Prospective memory impairment in long-term opiate users. Psychopharmacology. 231: 2623-32. PMID 24448901 DOI: 10.1007/s00213-014-3432-6  0.245
1993 Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. European Journal of Clinical Pharmacology. 44: 529-33. PMID 8405007 DOI: 10.1007/BF02440853  0.244
1988 Curran HV, Schiwy W, Eves F, Shine P, Lader M. A ?levels of processing? study of the effects of benzodiazepines on human memory Human Psychopharmacology: Clinical and Experimental. 3: 21-25. DOI: 10.1002/hup.470030105  0.243
2015 Das RK, Hindocha C, Freeman TP, Lazzarino AI, Curran HV, Kamboj SK. Assessing the translational feasibility of pharmacological drug memory reconsolidation blockade with memantine in quitting smokers. Psychopharmacology. 232: 3363-74. PMID 26093656 DOI: 10.1007/S00213-015-3990-2  0.243
2016 Morgan CJ, Freeman TP, Powell J, Curran HV. AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. Translational Psychiatry. 6: e738. PMID 26882038 DOI: 10.1038/tp.2015.219  0.243
2004 Morgan CJ, Riccelli M, Maitland CH, Curran HV. Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Drug and Alcohol Dependence. 75: 301-8. PMID 15283951 DOI: 10.1016/J.DRUGALCDEP.2004.03.006  0.239
2001 Curran HV, Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction (Abingdon, England). 96: 749-60. PMID 11331033 DOI: 10.1046/j.1360-0443.2001.96574910.x  0.239
1987 Curran HV, Schiwy W, Lader M. Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives. Psychopharmacology. 92: 358-64. PMID 3114788 DOI: 10.1007/BF00210844  0.239
1996 Pompéia S, Gorenstein C, Curran HV. Does potency determine amnestic effects of benzodiazepines? A dose-response comparison of flunitrazepam and nitrazepam. Behavioural Pharmacology. 7: 532-539. PMID 11224450  0.238
2006 Curran HV, Mintzer MZ. Psychopharmacology of memory. Psychopharmacology. 188: 393-6. PMID 17058106 DOI: 10.1007/S00213-006-0580-3  0.236
2015 Das RK, Hindocha C, Freeman TP, Lazzarino AI, Curran HV, Kamboj SK. Assessing the translational feasibility of pharmacological drug memory reconsolidation blockade with memantine in quitting smokers Psychopharmacology. DOI: 10.1007/s00213-015-3990-2  0.235
2016 Buckingham J, Moss A, Gyure K, Ralph N, Hindocha C, Lawn W, Curran HV, Freeman TP. A Moderate Dose of Alcohol Does Not Influence Experience of Social Ostracism in Hazardous Drinkers. Frontiers in Psychology. 7: 555. PMID 27148155 DOI: 10.3389/fpsyg.2016.00555  0.235
2005 Morgan CJ, Monaghan L, Curran HV. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction (Abingdon, England). 99: 1450-61. PMID 15500598 DOI: 10.1111/J.1360-0443.2004.00879.X  0.235
2012 Battistella S, Constantinou N, Morgan CJ, Davis P, O'Ryan D, Curran HV. Semantic priming and verbal learning in current opiate users, ex-users and non-user controls. Human Psychopharmacology. 27: 499-506. PMID 22996617 DOI: 10.1002/hup.2255  0.234
1994 Allen D, Curran HV, Lader M. The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers. European Journal of Clinical Pharmacology. 45: 313-20. PMID 8299662 DOI: 10.1007/BF00265947  0.234
2012 Bloomfield M, Morgan C, Egerton A, Kapur S, Curran H, Howes O. P.3.029 Chronic cannabis use and dopamine synthesis capacity: an [18F]-DOPA positron emission tomography study European Neuropsychopharmacology. 22: S76-S77. DOI: 10.1016/S0924-977X(12)70082-2  0.233
2022 Lawn W, Fernandez-Vinson N, Mokrysz C, Hogg G, Lees R, Trinci K, Petrilli K, Borissova A, Ofori S, Waters S, Michór P, Wall MB, Freeman TP, Curran HV. Correction to: The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age‑matched controls. Psychopharmacology. 239: 2371. PMID 35648202 DOI: 10.1007/s00213-022-06169-7  0.233
2012 Bloomfield M, Morgan C, Egerton A, Kapur S, Curran H, Howes O. P.6.c.011 Dopaminergic function in cannabis users: an 18[F]-DOPA positron emission tomography study of dopamine synthesis capacity European Neuropsychopharmacology. 22: S404. DOI: 10.1016/S0924-977X(12)70631-4  0.231
2014 Mokrysz C, Gage S, Landy R, Munafò M, Roiser J, Curran H. P.6.d.016 Neuropsychological and educational outcomes related to adolescent cannabis use, a prospective cohort study European Neuropsychopharmacology. 24: S695-S696. DOI: 10.1016/S0924-977X(14)71121-6  0.229
2004 Iliffe S, Curran HV, Collins R, Kee SCY, Fletcher S, Woods B. Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers Aging & Mental Health. 8: 242-248. PMID 15203405 DOI: 10.1080/13607860410001669778  0.223
1991 Curran HV, Birch B. Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil. Psychopharmacology. 103: 519-23. PMID 1676530 DOI: 10.1007/BF02244252  0.221
2021 Skumlien M, Langley C, Lawn W, Voon V, Curran HV, Roiser JP, Sahakian BJ. The acute and non-acute effects of cannabis on reward processing: A systematic review. Neuroscience and Biobehavioral Reviews. PMID 34509513 DOI: 10.1016/j.neubiorev.2021.09.008  0.219
2014 Freeman T, Morgan C, Hindocha C, Schafer G, Das R, Curran H. P.6.d.018 Effects of delta-9-tetrahydrocannabinol and cannabidiol on estimated cannabis potency and actual titration European Neuropsychopharmacology. 24: S696-S697. DOI: 10.1016/S0924-977X(14)71123-X  0.219
1989 Curran HV, Sakulsriprong M, Lader M. Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles Psychopharmacology. 97: 139-139. DOI: 10.1007/BF00443428  0.219
2017 Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. PMID 29119217 DOI: 10.1007/S00213-017-4771-X  0.217
2007 Klaassen E, Morgan C, Cregg R, Nagaratnam M, Brandner B, Curran H. P.3.b.005 The role of dopamine and glutamate in superstition: an investigation using ketamine European Neuropsychopharmacology. 17: S420. DOI: 10.1016/S0924-977X(07)70631-4  0.216
2006 Brignell CM, Curran HV. Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning. Psychopharmacology. 186: 504-16. PMID 16758238 DOI: 10.1007/s00213-006-0363-x  0.213
1993 Curran HV, Gorenstein C. Differential effects of lorazepam and oxazepam on priming. International Clinical Psychopharmacology. 8: 37-42. PMID 8473719 DOI: 10.1097/00004850-199300810-00006  0.212
2016 Lawn W, Freeman TP, Pope RA, Joye A, Harvey L, Hindocha C, Mokrysz C, Moss A, Wall MB, Bloomfield MA, Das RK, Morgan CJ, Nutt DJ, Curran HV. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology. PMID 27585792 DOI: 10.1007/S00213-016-4383-X  0.212
2006 Martin L, Clair J, Davis P, O'Ryan D, Hoshi R, Curran HV. Enhanced recognition of facial expressions of disgust in opiate users receiving maintenance treatment. Addiction (Abingdon, England). 101: 1598-605. PMID 17034439 DOI: 10.1111/j.1360-0443.2006.01574.x  0.21
2020 Lawn W, Hill J, Hindocha C, Yim J, Yamamori Y, Jones G, Walker H, Green SF, Wall MB, Howes OD, Curran HV, Freeman TP, Bloomfield MA. The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 269881120944148. PMID 32755273 DOI: 10.1177/0269881120944148  0.21
1988 Allen D, Lader M, Curran HV. A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 63-80. PMID 3259002 DOI: 10.1016/0278-5846(88)90062-0  0.207
2017 Hindocha C, Freeman TP, Xia JX, Shaban NDC, Curran HV. Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial. Psychological Medicine. 1-12. PMID 28558859 DOI: 10.1017/S0033291717001222  0.207
2019 Freeman AM, Petrilli K, Lees R, Hindocha C, Mokrysz C, Curran HV, Saunders R, Freeman TP. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neuroscience and Biobehavioral Reviews. PMID 31580839 DOI: 10.1016/j.neubiorev.2019.09.036  0.206
2016 Nutt D, Carhart-Harris RL, Curran H. Recent insights into the psychopharmacology of MDMA European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)30947-6  0.205
2020 Bloomfield MAP, Green SF, Hindocha C, Yamamori Y, Yim JLL, Jones APM, Walker HR, Tokarczuk P, Statton B, Howes OD, Curran HV, Freeman TP. The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study. Journal of Psychopharmacology (Oxford, England). 269881120936419. PMID 32762272 DOI: 10.1177/0269881120936419  0.204
2006 Morgan CJ, Curran HV. Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology. 188: 408-24. PMID 17006715 DOI: 10.1007/s00213-006-0572-3  0.204
2011 Kamboj SK, Massey-Chase R, Rodney L, Das R, Almahdi B, Curran HV, Morgan CJ. Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of D-cycloserine in heavy drinkers. Psychopharmacology. 217: 25-37. PMID 21455709 DOI: 10.1007/S00213-011-2254-Z  0.202
2016 Mokrysz C, Freeman TP, Korkki S, Griffiths K, Curran HV. Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Translational Psychiatry. 6: e961. PMID 27898071 DOI: 10.1038/tp.2016.225  0.201
2021 Kotoula V, Stringaris A, Mackes N, Mazibuko N, Hawkins PCT, Furey M, Curran HV, Mehta MA. Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission from Depression. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 34126264 DOI: 10.1016/j.bpsc.2021.05.009  0.201
2022 Grabski M, McAndrew A, Lawn W, Marsh B, Raymen L, Stevens T, Hardy L, Warren F, Bloomfield M, Borissova A, Maschauer E, Broomby R, Price R, Coathup R, Gilhooly D, ... ... Curran HV, et al. Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. The American Journal of Psychiatry. appiajp202121030277. PMID 35012326 DOI: 10.1176/appi.ajp.2021.21030277  0.199
2010 Morgan CJ, Freeman TP, Schafer GL, Curran HV. Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1879-85. PMID 20428110 DOI: 10.1038/npp.2010.58  0.198
2022 Skumlien M, Mokrysz C, Freeman TP, Wall MB, Bloomfield M, Lees R, Borissova A, Petrilli K, Carson J, Coughlan T, Ofori S, Langley C, Sahakian BJ, Curran HV, Lawn W. Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35388175 DOI: 10.1038/s41386-022-01316-2  0.198
2012 Curran HV, Allen D, Lader M. The effects of single doses of alpidem and lorazepam on memory and psychomotor performance in normal humans. Journal of Psychopharmacology (Oxford, England). 1: 81-9. PMID 22158888 DOI: 10.1177/026988118700100204  0.198
2023 Van Dyck E, Ponnet K, Van Havere T, Hauspie B, Dirkx N, Schrooten J, Waldron J, Grabski M, Freeman TP, Curran HV, De Neve J. Substance Use and Attendance Motives of Electronic Dance Music (EDM) Event Attendees: A Survey Study. International Journal of Environmental Research and Public Health. 20. PMID 36767188 DOI: 10.3390/ijerph20031821  0.198
2016 Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH. Keep off the grass? Cannabis, cognition and addiction. Nature Reviews. Neuroscience. PMID 27052382 DOI: 10.1038/Nrn.2016.28  0.197
1995 Schifano F, Curran HV. Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall. Psychopharmacology. 115: 430-4. PMID 7871085 DOI: 10.1007/BF02245086  0.194
2009 Stefanovic A, Brandner B, Klaassen E, Cregg R, Nagaratnam M, Bromley LM, Das RK, Rossell SL, Morgan CJ, Curran HV. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia? Journal of Clinical Psychopharmacology. 29: 124-33. PMID 19512973 DOI: 10.1097/Jcp.0B013E31819A4B91  0.188
2015 Freeman TP, Das RK, Kamboj SK, Curran HV. Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward. Social Cognitive and Affective Neuroscience. 10: 85-92. PMID 24526184 DOI: 10.1093/Scan/Nsu026  0.186
2013 Freeman TP, Morgan CJ, Brandner B, Almahdi B, Curran HV. Dopaminergic involvement in effort-based but not impulsive reward processing in smokers. Drug and Alcohol Dependence. 130: 109-14. PMID 23182407 DOI: 10.1016/j.drugalcdep.2012.10.016  0.186
2015 Hindocha C, Freeman TP, Schafer G, Gardener C, Das RK, Morgan CJ, Curran HV. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 325-34. PMID 25534187 DOI: 10.1016/J.Euroneuro.2014.11.014  0.186
2024 Hall D, Lawn W, Ofori S, Trinci K, Borissova A, Mokrysz C, Petrilli K, Bloomfield MAP, Wall MB, Freeman TP, Curran HV. The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study. Psychopharmacology. PMID 38416223 DOI: 10.1007/s00213-024-06543-7  0.185
1998 Fluck E, Fernandes C, File SE, Curran HV, Marshall J. The influence of alcoholism and cirrhosis on benzodiazepine receptor function. Pharmacology, Biochemistry, and Behavior. 59: 949-54. PMID 9586854 DOI: 10.1016/s0091-3057(97)00513-3  0.184
1991 Allen D, Curran HV, Lader M. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects. European Journal of Clinical Pharmacology. 40: 355-62. PMID 2050170 DOI: 10.1007/BF00265843  0.182
2022 Lawn W, Fernandez-Vinson N, Mokrysz C, Hogg G, Lees R, Trinci K, Petrilli K, Borissova A, Ofori S, Waters S, Michór P, Wall MB, Freeman TP, Curran HV. The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls. Psychopharmacology. 239: 1629-1641. PMID 35486121 DOI: 10.1007/s00213-022-06143-3  0.182
1996 Kapczinski F, Curran HV, Przemioslo R, Williams R, Fluck E, Fernandes C, File SE. Cognitive impairments of alcoholic cirrhotic patients: Correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors Journal of Neurology Neurosurgery and Psychiatry. 60: 676-680. PMID 8648337 DOI: 10.1136/Jnnp.60.6.676  0.181
2021 Feltmann K, Elgán TH, Strandberg AK, Kvillemo P, Jayaram-Lindström N, Grabski M, Waldron J, Freeman T, Curran HV, Gripenberg J. Illicit Drug Use and Associated Problems in the Nightlife Scene: A Potential Setting for Prevention. International Journal of Environmental Research and Public Health. 18. PMID 33946164 DOI: 10.3390/ijerph18094789  0.18
2018 Hindocha C, Freeman TP, Grabski M, Stroud JB, Crudgington H, Davies AC, Das RK, Lawn W, Morgan CJA, Curran HV. Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction (Abingdon, England). PMID 29714034 DOI: 10.1111/Add.14243  0.177
2013 Das RK, Kamboj SK, Ramadas M, Yogan K, Gupta V, Redman E, Curran HV, Morgan CJ. Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology. 226: 781-92. PMID 23307069 DOI: 10.1007/S00213-012-2955-Y  0.176
2017 Lawn W, Freeman TP, East K, Gaule A, Aston ER, Bloomfield MAP, Das RK, Morgan CJA, Curran HV. The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 29065193 DOI: 10.1093/Ntr/Ntx159  0.173
2016 Kamboj SK, Place H, Barton JA, Linke S, Curran HV, Harris PR. Processing of Alcohol-Related Health Threat in At-Risk Drinkers: An Online Study of Gender-Related Self-Affirmation Effects. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 26993737 DOI: 10.1093/alcalc/agw013  0.171
2017 Hindocha C, Lawn W, Freeman TP, Curran HV. Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users. Psychopharmacology. PMID 28733813 DOI: 10.1007/s00213-017-4698-2  0.17
2016 Mercuri K, Terrett G, Bailey PE, Henry JD, Curran HV, Rendell PG. Deconstructing the nature of episodic foresight deficits associated with chronic opiate use. The British Journal of Clinical Psychology / the British Psychological Society. PMID 26971561 DOI: 10.1111/bjc.12110  0.169
2022 Skumlien M, Mokrysz C, Freeman TP, Valton V, Wall MB, Bloomfield M, Lees R, Borissova A, Petrilli K, Giugliano M, Clisu D, Langley C, Sahakian BJ, Curran HV, Lawn W. Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls. The International Journal of Neuropsychopharmacology. PMID 35999024 DOI: 10.1093/ijnp/pyac056  0.169
2014 Bloomfield MA, Morgan CJ, Kapur S, Curran HV, Howes OD. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology. 231: 2251-9. PMID 24696078 DOI: 10.1007/s00213-014-3523-4  0.168
2009 Morgan CJ, Huddy V, Lipton M, Curran HV, Joyce EM. Is persistent ketamine use a valid model of the cognitive and oculomotor deficits in schizophrenia? Biological Psychiatry. 65: 1099-102. PMID 19111280 DOI: 10.1016/j.biopsych.2008.10.045  0.167
2005 Hoshi R, Bisla J, Curran HV. The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings. Drug and Alcohol Dependence. 76: 297-304. PMID 15561480 DOI: 10.1016/J.DRUGALCDEP.2004.06.006  0.166
2019 Kamboj SK, Gong AT, Sim Z, Rashid AA, Baba A, Iskandar G, Das RK, Curran HV. Reduction in the occurrence of distressing involuntary memories following propranolol or hydrocortisone in healthy women. Psychological Medicine. 1-8. PMID 31084640 DOI: 10.1017/S0033291719001028  0.165
2014 Hindocha C, Wollenberg O, Carter Leno V, Alvarez BO, Curran HV, Freeman TP. Emotional processing deficits in chronic cannabis use: a replication and extension. Journal of Psychopharmacology (Oxford, England). 28: 466-71. PMID 24646810 DOI: 10.1177/0269881114527359  0.163
2012 Kamboj SK, Joye A, Das RK, Gibson AJ, Morgan CJ, Curran HV. Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias. Psychopharmacology. 221: 273-84. PMID 22101394 DOI: 10.1007/S00213-011-2571-2  0.161
2003 Richardson M, Powell JH, Curran HV. Effects of cigarette smoking on reward responsivity and cognitive function in brain injured individuals. Neuropsychological Rehabilitation. 13: 365-78. PMID 21854318 DOI: 10.1080/09602010343000011  0.161
2007 Hoshi R, Cohen L, Lemanski L, Piccini P, Bond A, Curran HV. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls. Experimental and Clinical Psychopharmacology. 15: 351-8. PMID 17696682 DOI: 10.1037/1064-1297.15.4.351  0.16
2021 Freeman AM, Mokrysz C, Hindocha C, Lawn W, Morgan CJ, Freeman TP, Saunders R, Curran HV. Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis. Journal of Psychopharmacology (Oxford, England). 269881120959601. PMID 33427016 DOI: 10.1177/0269881120959601  0.16
1997 Curran HV, Travill RA. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction (Abingdon, England). 92: 821-31. PMID 9293041  0.158
2009 Freeman TP, Morgan CJ, Klaassen E, Das RK, Stefanovic A, Brandner B, Curran HV. Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans. Psychopharmacology. 206: 563-73. PMID 19436994 DOI: 10.1007/S00213-009-1564-X  0.157
2010 Platt B, Kamboj S, Morgan CJ, Curran HV. Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions. Drug and Alcohol Dependence. 112: 27-32. PMID 21036306 DOI: 10.1016/J.Drugalcdep.2010.05.004  0.157
2007 Hoshi R, Mullins K, Boundy C, Brignell C, Piccini P, Curran HV. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. Psychopharmacology. 194: 371-9. PMID 17605005 DOI: 10.1007/s00213-007-0837-5  0.156
1999 Curran HV, Bolton J, Wanigaratne S, Smyth C. Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment. Addiction (Abingdon, England). 94: 665-74. PMID 10563031 DOI: 10.1046/j.1360-0443.1999.9456654.x  0.156
2020 Mokrysz C, Shaban NDC, Freeman TP, Lawn W, Pope RA, Hindocha C, Freeman A, Wall MB, Bloomfield MAP, Morgan CJA, Nutt DJ, Curran HV. Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence. Psychological Medicine. 1-9. PMID 32340632 DOI: 10.1017/S0033291720001038  0.154
2022 Wall MB, Freeman TP, Hindocha C, Demetriou L, Ertl N, Freeman AM, Jones AP, Lawn W, Pope R, Mokrysz C, Solomons D, Statton B, Walker HR, Yamamori Y, Yang Z, ... ... Curran HV, et al. Individual and combined effects of cannabidiol and Δ-tetrahydrocannabinol on striato-cortical connectivity in the human brain. Journal of Psychopharmacology (Oxford, England). 36: 732-744. PMID 35596578 DOI: 10.1177/02698811221092506  0.153
2013 Morgan CJ, Noronha LA, Muetzelfeldt M, Fielding A, Curran HV. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users. Journal of Psychopharmacology (Oxford, England). 27: 497-506. PMID 23438502 DOI: 10.1177/0269881113477744  0.153
1986 Curran HV, Lader M. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects. European Journal of Clinical Pharmacology. 29: 601-7. PMID 3082644 DOI: 10.1007/BF00635900  0.152
2017 Hindocha C, Freeman TP, Curran HV. Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration. Cannabis and Cannabinoid Research. 2: 217-223. PMID 29082319 DOI: 10.1089/can.2017.0024  0.152
2019 Wall MB, Pope R, Freeman TP, Kowalczyk OS, Demetriou L, Mokrysz C, Hindocha C, Lawn W, Bloomfield MA, Freeman AM, Feilding A, Nutt DJ, Curran HV. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. Journal of Psychopharmacology (Oxford, England). 269881119841568. PMID 31013455 DOI: 10.1177/0269881119841568  0.151
2010 Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction (Abingdon, England). 105: 121-33. PMID 19919593 DOI: 10.1111/j.1360-0443.2009.02761.x  0.15
2006 Shanks DR, Channon S, Wilkinson L, Curran HV. Disruption of sequential priming in organic and pharmacological amnesia: a role for the medial temporal lobes in implicit contextual learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1768-76. PMID 16237384 DOI: 10.1038/sj.npp.1300935  0.148
2010 Constantinou N, Morgan CJ, Battistella S, O'Ryan D, Davis P, Curran HV. Attentional bias, inhibitory control and acute stress in current and former opiate addicts. Drug and Alcohol Dependence. 109: 220-5. PMID 20172662 DOI: 10.1016/j.drugalcdep.2010.01.012  0.147
2009 Pine A, Seymour B, Roiser JP, Bossaerts P, Friston KJ, Curran HV, Dolan RJ. Encoding of marginal utility across time in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9575-81. PMID 19641120 DOI: 10.1523/Jneurosci.1126-09.2009  0.147
2010 Morgan CJ, Muetzelfeldt L, Muetzelfeldt M, Nutt DJ, Curran HV. Harms associated with psychoactive substances: findings of the UK National Drug Survey. Journal of Psychopharmacology (Oxford, England). 24: 147-53. PMID 19939875 DOI: 10.1177/0269881109106915  0.147
2014 Krol KM, Kamboj SK, Curran HV, Grossmann T. Breastfeeding experience differentially impacts recognition of happiness and anger in mothers. Scientific Reports. 4: 7006. PMID 25387686 DOI: 10.1038/Srep07006  0.146
2004 Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV. Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study. Psychopharmacology. 172: 298-308. PMID 14727004 DOI: 10.1007/s00213-003-1656-y  0.145
2005 Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain. 117: 388-95. PMID 16198201 DOI: 10.1016/j.pain.2005.06.022  0.143
2020 Borissova A, Ferguson B, Wall MB, Morgan CJ, Carhart-Harris RL, Bolstridge M, Bloomfield MA, Williams TM, Feilding A, Murphy K, Tyacke RJ, Erritzoe D, Stewart L, Wolff K, Nutt D, ... Curran HV, et al. Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. Journal of Psychopharmacology (Oxford, England). 269881120926673. PMID 32538252 DOI: 10.1177/0269881120926673  0.142
2013 Freeman TP, Morgan CJ, Pepper F, Howes OD, Stone JM, Curran HV. Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use. Psychopharmacology. 225: 41-50. PMID 22829431 DOI: 10.1007/s00213-012-2791-0  0.142
2014 Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, ... ... Curran HV, et al. The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity. Biological Psychiatry. PMID 24495461 DOI: 10.1016/J.Biopsych.2013.12.015  0.142
2012 Freeman TP, Morgan CJ, Vaughn-Jones J, Hussain N, Karimi K, Curran HV. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'. Addiction (Abingdon, England). 107: 792-800. PMID 22257011 DOI: 10.1111/j.1360-0443.2011.03719.x  0.139
2009 Morgan CJ, Muetzelfeldt L, Curran HV. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction (Abingdon, England). 104: 77-87. PMID 19133891 DOI: 10.1111/j.1360-0443.2008.02394.x  0.139
2000 Curran HV, Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction (Abingdon, England). 95: 575-90. PMID 10829333 DOI: 10.1046/j.1360-0443.2000.9545759.x  0.139
2014 Edward Roberts R, Curran HV, Friston KJ, Morgan CJ. Abnormalities in white matter microstructure associated with chronic ketamine use. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 329-38. PMID 23929545 DOI: 10.1038/npp.2013.195  0.138
2022 Skumlien M, Freeman TP, Hall D, Mokrysz C, Wall MB, Ofori S, Petrilli K, Trinci K, Borissova A, Fernandez-Vinson N, Langley C, Sahakian BJ, Curran HV, Lawn W. The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 36642667 DOI: 10.1016/j.bpsc.2022.10.004  0.136
2020 Grabski M, Borissova A, Marsh B, Morgan CJA, Curran HV. Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review. Behavioural Brain Research. 112629. PMID 32485203 DOI: 10.1016/j.bbr.2020.112629  0.135
2002 Zangara A, Blair RJ, Curran HV. A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions. Psychopharmacology. 163: 36-41. PMID 12185398 DOI: 10.1007/s00213-002-1120-4  0.135
2011 Tai YF, Hoshi R, Brignell CM, Cohen L, Brooks DJ, Curran HV, Piccini P. Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 735-43. PMID 21160467 DOI: 10.1038/Npp.2010.201  0.135
2004 Verheyden SL, Maidment R, Curran HV. Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmacology (Oxford, England). 17: 371-8. PMID 14870948 DOI: 10.1177/0269881103174014  0.135
2015 Kamboj SK, Krol KM, Curran HV. A specific association between facial disgust recognition and estradiol levels in naturally cycling women. Plos One. 10: e0122311. PMID 25874795 DOI: 10.1371/Journal.Pone.0122311  0.134
2007 Uhlhaas PJ, Millard I, Muetzelfeldt L, Curran HV, Morgan CJ. Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later. Journal of Psychopharmacology (Oxford, England). 21: 347-52. PMID 17591661 DOI: 10.1177/0269881107077739  0.133
2023 Lees R, Hines LA, Hindocha C, Baio G, Shaban NDC, Stothart G, Mofeez A, Morgan CJA, Curran HV, Freeman TP. Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder. Psychopharmacology. 240: 337-346. PMID 36598543 DOI: 10.1007/s00213-022-06303-5  0.133
2016 Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R. Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. Jama Psychiatry. PMID 26842658 DOI: 10.1001/Jamapsychiatry.2015.3278  0.132
2015 Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL. LSD enhances the emotional response to music. Psychopharmacology. 232: 3607-14. PMID 26257162 DOI: 10.1007/S00213-015-4014-Y  0.131
2019 Hindocha C, Freeman TP, Schafer G, Gardner C, Bloomfield MAP, Bramon E, Morgan CJA, Curran HV. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Addiction Biology. e12762. PMID 31013550 DOI: 10.1111/adb.12762  0.13
2013 Morgan CJ, Das RK, Joye A, Curran HV, Kamboj SK. Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addictive Behaviors. 38: 2433-6. PMID 23685330 DOI: 10.1016/J.Addbeh.2013.03.011  0.129
2006 Morgan CJ, Rossell SL, Pepper F, Smart J, Blackburn J, Brandner B, Curran HV. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry. 59: 265-72. PMID 16140283 DOI: 10.1016/j.biopsych.2005.06.018  0.128
2023 Lawn W, Trinci K, Mokrysz C, Borissova A, Ofori S, Petrilli K, Bloomfield M, Haniff ZR, Hall D, Fernandez-Vinson N, Wang S, Englund A, Chesney E, Wall MB, Freeman TP, ... Curran HV, et al. THE ACUTE EFFECTS OF CANNABIS WITH AND WITHOUT CANNABIDIOL IN ADULTS AND ADOLESCENTS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER EXPERIMENT. Addiction (Abingdon, England). PMID 36750134 DOI: 10.1111/add.16154  0.126
2012 Morgan CJ, Duffin S, Hunt S, Monaghan L, Mason O, Curran HV. Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaine. Pharmacopsychiatry. 45: 269-74. PMID 22511328 DOI: 10.1055/s-0032-1306310  0.126
2011 Carroll EM, Kamboj SK, Conroy L, Tookman A, Williams AC, Jones L, Morgan CJ, Curran HV. Facial affect processing in patients receiving opioid treatment in palliative care: preferential processing of threat in pain catastrophizers. Journal of Pain and Symptom Management. 41: 975-85. PMID 21251795 DOI: 10.1016/j.jpainsymman.2010.08.011  0.126
2023 Hua DY, Hindocha C, Baio G, Lees R, Shaban N, Morgan CJ, Mofeez A, Curran HV, Freeman TP. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational Psychiatry. 13: 131. PMID 37085531 DOI: 10.1038/s41398-023-02410-9  0.126
2016 Grabski M, Curran HV, Nutt DJ, Husbands SM, Freeman TP, Fluharty M, Munafò MR. Behavioral tasks sensitive to acute abstinence and predictive of smoking cessation success: A systematic review and meta-analysis. Addiction (Abingdon, England). PMID 27338804 DOI: 10.1111/Add.13507  0.126
2015 Hindocha C, Shaban ND, Freeman TP, Das RK, Gale G, Schafer G, Falconer CJ, Morgan CJ, Curran HV. Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom. Drug and Alcohol Dependence. 148: 165-71. PMID 25622777 DOI: 10.1016/J.Drugalcdep.2015.01.004  0.124
2021 Sessa B, Aday JS, O'Brien S, Curran HV, Measham F, Higbed L, Nutt DJ. Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA. Journal of Psychopharmacology (Oxford, England). 2698811211055809. PMID 34894842 DOI: 10.1177/02698811211055809  0.124
2012 Birch B, Curran HV. The differential effects of flumazenil on the psychomotor and amnesic actions of midazolam. Journal of Psychopharmacology (Oxford, England). 4: 29-34. PMID 22282924 DOI: 10.1177/026988119000400105  0.124
2022 Borissova A, Soni S, Aston ER, Lees R, Petrilli K, Wall MB, Bloomfield MAP, Mertzani E, Paksina A, Freeman TP, Mokrysz C, Lawn W, Curran HV. Age differences in the behavioural economics of cannabis use: Do adolescents and adults differ on demand for cannabis and discounting of future reward? Drug and Alcohol Dependence. 238: 109531. PMID 35809475 DOI: 10.1016/j.drugalcdep.2022.109531  0.123
2000 Blair RJ, Curran HV. Selective impairment in the recognition of anger induced by diazepam. Psychopharmacology. 147: 335-8. PMID 10639695 DOI: 10.1007/s002130051177  0.122
2019 Gong AT, Kamboj SK, Curran HV. Post-traumatic Stress Disorder in Victims of Sexual Assault With Pre-assault Substance Consumption: A Systematic Review. Frontiers in Psychiatry. 10: 92. PMID 30918487 DOI: 10.3389/fpsyt.2019.00092  0.121
2024 Lees R, Lawn W, Petrilli K, Brown A, Trinci K, Borissova A, Ofori S, Mokrysz C, Curran HV, Hines LA, Freeman TP. Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European Archives of Psychiatry and Clinical Neuroscience. PMID 38709252 DOI: 10.1007/s00406-024-01806-y  0.12
2016 Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, ... ... Curran HV, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the United States of America. PMID 27071089 DOI: 10.1073/Pnas.1518377113  0.119
2014 Freeman TP, Mokrysz C, Curran HV. Rethinking dose-response effects of cannabis use in adolescence. The Lancet. Psychiatry. 1: 416. PMID 26361186 DOI: 10.1016/S2215-0366(14)00005-4  0.118
2018 Curran HV, Hindocha C, Morgan CJA, Shaban N, Das RK, Freeman TP. Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Psychological Medicine. 1-7. PMID 30176957 DOI: 10.1017/S003329171800226X  0.115
2004 Curran HV, Rees H, Hoare T, Hoshi R, Bond A. Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology. 173: 425-33. PMID 14735288 DOI: 10.1007/s00213-003-1713-6  0.115
2006 Hoshi R, Pratt H, Mehta S, Bond AJ, Curran HV. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences? Journal of Psychopharmacology (Oxford, England). 20: 291-301. PMID 16510487 DOI: 10.1177/0269881106060505  0.113
2012 Morgan CJ, Curran HV. Ketamine use: a review. Addiction (Abingdon, England). 107: 27-38. PMID 21777321 DOI: 10.1111/j.1360-0443.2011.03576.x  0.113
2003 Curran HV, Verheyden SL. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology. 169: 91-103. PMID 12759801 DOI: 10.1007/s00213-003-1463-5  0.113
2017 Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports. 7: 13187. PMID 29030624 DOI: 10.1038/S41598-017-13282-7  0.112
2023 Ertl N, Lawn W, Mokrysz C, Freeman TP, Alnagger N, Borissova A, Fernandez-Vinson N, Lees R, Ofori S, Petrilli K, Trinci K, Viding E, Curran HV, Wall MB. Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults. Journal of Psychopharmacology (Oxford, England). 2698811231189441. PMID 37515469 DOI: 10.1177/02698811231189441  0.111
2002 Verheyden SL, Hadfield J, Calin T, Curran HV. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology. 161: 23-31. PMID 11967627 DOI: 10.1007/s00213-001-0995-9  0.111
2003 Verheyden SL, Henry JA, Curran HV. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Human Psychopharmacology. 18: 507-17. PMID 14533132 DOI: 10.1002/hup.529  0.11
2021 Bloomfield MAP, Petrilli K, Lees R, Hindocha C, Beck K, Turner RJ, Onwordi EC, Rane N, Lythgoe DJ, Stone JM, Curran HV, Howes OD, Freeman TP. The Effects of Acute Δ-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 6: 660-667. PMID 34099186 DOI: 10.1016/j.bpsc.2021.04.013  0.108
2019 Grabski M, Curran HV, Nutt DJ, Husbands SM, Ferguson SG, Munafò MR. The development and validation of a human screening model of tobacco abstinence. Drug and Alcohol Dependence. 206: 107720. PMID 31790979 DOI: 10.1016/J.Drugalcdep.2019.107720  0.107
2023 Petrilli K, Hines L, Adams S, Morgan CJ, Curran HV, Freeman TP. High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence. Addictive Behaviors. 144: 107740. PMID 37121087 DOI: 10.1016/j.addbeh.2023.107740  0.107
2009 Stokes PR, Mehta MA, Curran HV, Breen G, Grasby PM. Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage. 48: 186-90. PMID 19539765 DOI: 10.1016/J.Neuroimage.2009.06.029  0.107
1994 Kapczinski F, Curran HV, Gray J, Lader M. Flumazenil has an anxiolytic effect in simulated stress Psychopharmacology. 114: 187-189. PMID 7846203 DOI: 10.1007/BF02245463  0.107
2009 Selvaraj S, Hoshi R, Bhagwagar Z, Murthy NV, Hinz R, Cowen P, Curran HV, Grasby P. Brain serotonin transporter binding in former users of MDMA ('ecstasy'). The British Journal of Psychiatry : the Journal of Mental Science. 194: 355-9. PMID 19336788 DOI: 10.1192/bjp.bp.108.050344  0.107
2014 Freeman TP, Morgan CJ, Hindocha C, Schafer G, Das RK, Curran HV. Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints? Addiction (Abingdon, England). 109: 1686-94. PMID 24894801 DOI: 10.1111/Add.12634  0.106
2019 Hindocha C, Freeman T, Bloomfield M, Bramon E, Morgan C, Curran H. P.147 Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the cannabinoid receptor 1 and FAAH enzyme European Neuropsychopharmacology. 29: S116-S117. DOI: 10.1016/j.euroneuro.2019.09.196  0.105
2006 Curran HV, Robjant K. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy. Journal of Psychopharmacology (Oxford, England). 20: 425-31. PMID 16574717 DOI: 10.1177/0269881106060584  0.105
2014 Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R, Ramsey J, Sweanor D. Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research. 20: 218-25. PMID 24714502 DOI: 10.1159/000360220  0.105
2008 Morgan CJ, Curran HV. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. The British Journal of Psychiatry : the Journal of Mental Science. 192: 306-7. PMID 18378995 DOI: 10.1192/bjp.bp.107.046649  0.105
2014 Bloomfield MA, Morgan CJ, Egerton A, Kapur S, Curran HV, Howes OD. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biological Psychiatry. 75: 470-8. PMID 23820822 DOI: 10.1016/j.biopsych.2013.05.027  0.104
2015 Kamboj SK, Kilford EJ, Minchin S, Moss A, Lawn W, Das RK, Falconer CJ, Gilbert P, Curran HV, Freeman TP. Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or 'ecstasy' and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices. Journal of Psychopharmacology (Oxford, England). 29: 961-70. PMID 25990558 DOI: 10.1177/0269881115587143  0.103
2021 Schlag AK, Hindocha C, Zafar R, Nutt DJ, Curran HV. Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology (Oxford, England). 269881120986393. PMID 33593117 DOI: 10.1177/0269881120986393  0.099
2019 Akram H, Mokrysz C, Curran HV. What are the psychological effects of using synthetic cannabinoids? A systematic review. Journal of Psychopharmacology (Oxford, England). 33: 271-283. PMID 30789300 DOI: 10.1177/0269881119826592  0.099
1984 Lader MH, Curran HV. PSYCHOTROPIC EFFECTS OF REPEATED DOSES OF FLUVOXAMINE IN NORMAL SUBJECTS Clinical Neuropharmacology. 7: S316. DOI: 10.1097/00002826-198406001-00285  0.098
2013 Morgan CJ, Page E, Schaefer C, Chatten K, Manocha A, Gulati S, Curran HV, Brandner B, Leweke FM. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. The British Journal of Psychiatry : the Journal of Mental Science. 202: 381-2. PMID 23580381 DOI: 10.1192/Bjp.Bp.112.121178  0.096
2021 Nutt DJ, Phillips LD, Barnes MP, Brander B, Curran HV, Fayaz A, Finn DP, Horsted T, Moltke J, Sakal C, Sharon H, O'Sullivan SE, Williams T, Zorn G, Schlag AK. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products. Cannabis and Cannabinoid Research. PMID 33998895 DOI: 10.1089/can.2020.0129  0.096
2021 Grabski M, Waldron J, Freeman TP, Mokrysz C, van Beek RJJ, van der Pol P, Hauspie B, Dirkx N, Schrooten J, Elgán TH, Feltman K, Benedetti E, Scalia Tomba G, Fabi F, Molinaro S, ... ... Curran HV, et al. Drug Use Changes at the Individual Level: Results from a Longitudinal, Multisite Survey in Young Europeans Frequenting the Nightlife Scene. European Addiction Research. 1-6. PMID 34839293 DOI: 10.1159/000520118  0.095
2003 Bond AJ, Verheyden SL, Wingrove J, Curran HV. Angry cognitive bias, trait aggression and impulsivity in substance users. Psychopharmacology. 171: 331-9. PMID 13680074 DOI: 10.1007/s00213-003-1585-9  0.095
2012 Freeman TP, Curran HV. Supply always comes on the heels of demand: what effects do control strategies have on drug users themselves? Addiction (Abingdon, England). 107: 1903-5. PMID 23039750 DOI: 10.1111/j.1360-0443.2012.04032.x  0.095
2022 Lawn W, Mokrysz C, Lees R, Trinci K, Petrilli K, Skumlien M, Borissova A, Ofori S, Bird C, Jones G, Bloomfield MA, Das RK, Wall MB, Freeman TP, Curran HV. The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls. Journal of Psychopharmacology (Oxford, England). 2698811221108956. PMID 35772419 DOI: 10.1177/02698811221108956  0.093
2000 Curran HV. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology. 42: 34-41. PMID 10867554 DOI: 10.1159/000026668  0.091
2021 Daedelow LS, Banaschewski T, Berning M, Bokde ALW, Brühl R, Burke Quinlan E, Curran HV, Desrivières S, Flor H, Grigis A, Garavan H, Hardon A, Kaminski J, Martinot JL, Paillère Martinot ML, et al. Are psychotic-like experiences related to a discontinuation of cannabis consumption in young adults? Schizophrenia Research. 228: 271-279. PMID 33493775 DOI: 10.1016/j.schres.2021.01.002  0.091
2019 Terrett G, Mercuri K, Pizarro-Campagna E, Hugrass L, Curran HV, Henry JD, Rendell PG. Social cognition impairments in long-term opiate users in treatment. Journal of Psychopharmacology (Oxford, England). 34: 254-263. PMID 31556782 DOI: 10.1177/0269881119875981  0.09
2023 Robinson EA, Gleeson J, Arun AH, Clemente A, Gaillard A, Rossetti MG, Brambilla P, Bellani M, Crisanti C, Curran HV, Lorenzetti V. Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies. Frontiers in Neuroimaging. 2: 1129587. PMID 37554654 DOI: 10.3389/fnimg.2023.1129587  0.09
2020 Waldron J, Grabski M, Freeman TP, Mokrysz C, Hindocha C, Measham F, van Beek R, van der Pol P, Hauspie B, Dirkx N, Schrooten J, Elgán TH, Feltmann K, Benedetti E, Tomba GS, ... ... Curran HV, et al. "How do online and offline sampling compare in a multinational study of drug use and nightlife behaviour?" The International Journal On Drug Policy. 82: 102812. PMID 32554209 DOI: 10.1016/j.drugpo.2020.102812  0.089
2013 Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. Benzodiazepines: risks and benefits. A reconsideration. Journal of Psychopharmacology (Oxford, England). 27: 967-71. PMID 24067791 DOI: 10.1177/0269881113503509  0.087
2020 Freeman TP, Hindocha C, Baio G, Shaban NDC, Thomas EM, Astbury D, Freeman AM, Lees R, Craft S, Morrison PD, Bloomfield MAP, O'Ryan D, Kinghorn J, Morgan CJA, Mofeez A, ... Curran HV, et al. Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. The Lancet. Psychiatry. PMID 32735782 DOI: 10.1016/S2215-0366(20)30290-X  0.085
2018 Curran HV, Nutt D, de Wit H. Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation. Psychopharmacology. 235: 373-375. PMID 29445838 DOI: 10.1007/S00213-017-4822-3  0.085
2008 Mason OJ, Morgan CJ, Stefanovic A, Curran HV. The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research. 103: 138-42. PMID 18387788 DOI: 10.1016/j.schres.2008.02.020  0.082
1996 Bond AJ, Curran HV, Bruce MS, O'Sullivan G, Shine P. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam. Journal of Affective Disorders. 35: 117-23. PMID 8749839 DOI: 10.1016/0165-0327(95)00053-4  0.079
2021 Lorenzetti V, Hindocha C, Petrilli K, Griffiths P, Brown J, Castillo-Carniglia Á, Caulkins JP, Englund A, ElSohly MA, Gage SH, Groshkova T, Gual A, Hammond D, Lawn W, López-Pelayo H, ... ... Curran HV, et al. The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use. Addiction (Abingdon, England). PMID 34590359 DOI: 10.1111/add.15702  0.078
2023 Petrilli K, Lawn W, Lees R, Mokrysz C, Borissova A, Ofori S, Trinci K, Dos Santos R, Leitch H, Soni S, Hines LA, Lorenzetti V, Curran HV, Freeman TP. Enhanced cannabis timeline followback (EC-TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures. Addiction (Abingdon, England). PMID 38105033 DOI: 10.1111/add.16405  0.075
2014 Bloomfield M, Morgan C, Kapur S, Curran H. P.6.f.004 The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study European Neuropsychopharmacology. 24: S701. DOI: 10.1016/S0924-977X(14)71130-7  0.073
2022 Grabski M, Waldron J, Freeman TP, van Laar M, Curran HV. Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees. The International Journal On Drug Policy. 102: 103612. PMID 35151083 DOI: 10.1016/j.drugpo.2022.103612  0.072
2016 Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D. E-cigarettes are less harmful than smoking. Lancet (London, England). 387: 1160-2. PMID 27025332 DOI: 10.1016/S0140-6736(15)00253-6  0.071
2019 Curran HV, Hindocha C, Morgan C, Shaban NDC, Das R, Freeman TP. Reply to Vadhan et al. - Correspondence on Curran et al. (2018) 'Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like response'. Psychological Medicine. 1-2. PMID 30841938 DOI: 10.1017/S0033291719000345  0.068
2022 Lorenzetti V, Hindocha C, Petrilli K, Griffiths P, Brown J, Castillo-Carniglia Á, Caulkins JP, Englund A, ElSohly MA, Gage SH, Groshkova T, Gual A, Hammond D, Lawn W, López-Pelayo H, ... ... Curran HV, et al. The iCannTookit: A consensus-based, flexible framework for measuring contemporary cannabis use. Addiction (Abingdon, England). PMID 35603918 DOI: 10.1111/add.15956  0.068
1996 Duka T, Curran HV, Rusted JM, Weingartner HJ. Perspectives on cognitive psychopharmacology research. Behavioural Pharmacology. 7: 401-410. PMID 11224434  0.063
2020 Freeman TP, Hindocha C, Baio G, Curran HV. Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply. The Lancet. Psychiatry. 7: 840. PMID 32949514 DOI: 10.1016/S2215-0366(20)30376-X  0.058
2020 Smyth BP, Cannon M, Molodynski A, Curran HV, Eastwood N, Winstock AR. Would decriminalising personal use of cannabis lead to higher rates of mental illness? Bmj (Clinical Research Ed.). 368: l6975. PMID 31941646 DOI: 10.1136/bmj.l6975  0.053
2009 Blagrove M, Morgan CJ, Curran HV, Bromley L, Brandner B. The incidence of unpleasant dreams after sub-anaesthetic ketamine. Psychopharmacology. 203: 109-20. PMID 18949459 DOI: 10.1007/s00213-008-1377-3  0.042
2022 Lorenzetti V, Hindocha C, Petrilli K, Griffiths P, Brown J, Castillo-Carniglia Á, Caulkins JP, Englund A, ElSohly MA, Gage SH, Groshkova T, Gual A, Hammond D, Lawn W, López-Pelayo H, ... ... Curran HV, et al. The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings. Addiction (Abingdon, England). PMID 35289010 DOI: 10.1111/add.15855  0.04
2020 Schlag AK, Baldwin DS, Barnes M, Bazire S, Coathup R, Curran HV, McShane R, Phillips LD, Singh I, Nutt DJ. Medical cannabis in the UK: From principle to practice. Journal of Psychopharmacology (Oxford, England). 269881120926677. PMID 32522058 DOI: 10.1177/0269881120926677  0.037
2005 Miles A, Curran HV, Pearce S, Allan L. Managing constraint: the experience of people with chronic pain. Social Science & Medicine (1982). 61: 431-41. PMID 15893057 DOI: 10.1016/j.socscimed.2004.11.065  0.036
2016 Moss A, Curran HV, Bloomfield MA, Kamboj SK, Blackwell SE, Freeman TP. Bringing together pharmacological and psychological approaches to mental health research. The Lancet. Psychiatry. 3: 700-2. PMID 27475758 DOI: 10.1016/S2215-0366(16)30080-3  0.019
2009 Curran HV, D'Souza DC, Robbins TW, Fletcher P. Modelling psychosis. Psychopharmacology. 206: 513-4. PMID 19756521 DOI: 10.1007/s00213-009-1663-8  0.019
2016 Steckler T, Curran HV, de Wit H, Howes O, Hoyer D, Lucki I, Miczek KA, Morrow AL, Price LH, Robbins TW. Editorial: Reporting guidelines for psychopharmacology. Psychopharmacology. PMID 26915651 DOI: 10.1007/S00213-016-4252-7  0.016
2022 D'Souza DC, Curran HV. Editorial. Psychopharmacology. PMID 35316359 DOI: 10.1007/s00213-022-06110-y  0.015
Hide low-probability matches.